Lansoprazol Bluepharma

Lansoprazole, the active ingredient in Lansoprazol Bluepharma, is a proton pump inhibitor presented as an unspecified strength oral tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease, and as part of Helicobacter pylori eradication regimens.

GNH USA supplies Lansoprazol Bluepharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric proton pump to lower acid secretion, making it useful for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and promotes healing of the esophageal lining. - Erosive esophagitis: facilitates mucosal repair and symptom relief. - Peptic ulcer disease: supports ulcer healing by decreasing gastric acidity. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by creating a less acidic environment.

Lansoprazole may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional, may improve with food. - Abdominal pain: discomfort in the upper abdomen. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, difficulty breathing. - Clostridioides difficile infection: severe diarrhea, colitis. - Elevated liver enzymes: signs of hepatic stress. - Hypomagnesemia: low magnesium levels with prolonged use. - Stevens‑Johnson syndrome: severe skin rash and mucosal involvement. - Interstitial nephritis: kidney inflammation presenting with reduced urine output.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: prolonged therapy may cause hypomagnesemia. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Use caution in elderly patients: higher risk of fractures and bone loss. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Lansoprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atorvastatin: increased statin plasma concentrations. - Methotrexate: heightened risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR values. - Digoxin: potential increase in serum digoxin levels. - Diazepam: enhanced sedative effect.